A hepatitis B carrier is a person who is infected with the hepatitis B virus, has no signs and symptoms of hepatitis, has normal liver function and other tests, has been followed up more than three times in a row within one year, has serum ALT and AST within the normal range, and generally has no significant abnormalities in liver histological examination. Simply put, this means that the person is infected with hepatitis B, but there is no inflammation of the liver. Currently, there are about 93 million hepatitis B virus carriers in China. In the hepatitis B group, there is a majority of hepatitis B virus carriers who still lack a scientific, correct and comprehensive understanding of their status, resulting in patients’ neglect or unnecessary worry about themselves. 1. Neglect of hepatitis B virus carriers: Many hepatitis B virus carriers think that they can rest easy with normal liver function. Hepatitis B virus carriers need daily maintenance, reasonable nutrition, keep a happy spirit. Avoid alcohol and drugs that damage liver function. Pay attention to the combination of work and rest, do not overwork, so as not to induce hepatitis B activity. It is also necessary to check liver function, fetoprotein, hepatitis B index, ultrasound, etc. regularly at the hospital, usually once every six months, to detect abnormalities and treat them in time. If symptoms such as weakness, loss of appetite, yellow urine and discomfort in the right upper abdomen appear, go to a specialist hospital for early examination. 2, lack of health care awareness: liver biopsy results confirm that some of the carriers occur hepatitis, inflammatory activity is very mild, no obvious liver disease manifestations, easy to be ignored and not treated in a timely manner, the long-term accumulation of lesions can develop to a more serious chronic liver disease. Such inflammatory activity may go undetected through screening or several outpatient visits. Some require a liver biopsy for liver histology. 3.Mistake the markers turn negative as the purpose of treatment: Most hepatitis B virus carriers complain of “long treatment” based on the fact that hepatitis B has not turned negative, they believe that as long as HBeAg and HBsAg positivity is not eliminated, they can not get rid of the “hepatitis B” virus winding. In fact, positive hepatitis B markers only indicate infection with the hepatitis B virus and to some extent the level of virus replication in the body. For carriers, HBeAg and HBsAg are not pathogenic and do not reflect the extent of liver lesions. 4, listen to the propaganda of advertising: drug promoters take advantage of the carrier’s eagerness to “turn negative” and fear of the prognosis of hepatitis B, using drug advertising on the one hand to exaggerate the poor prognosis of hepatitis B, and on the other hand to extol the “miraculous effect” of turning negative, so that many people are deceived. Many carriers spend a lot of money on treatment with the hope and attitude of turning negative and end up penniless. In fact, hepatitis B virus carriers are in a state of immune tolerance, the body and the virus both coexist peacefully, the current antiviral treatment is ineffective and redundant. 5, misconceptions about hepatitis B virus carriers: some hepatitis B virus carriers think they are hepatitis B patients, some dare not get married, some married for many years dare not get pregnant, some couples have good feelings but live apart for a long time, and so on, carrying a great ideological burden, which affects normal life. In fact, the carrier liver function is normal, the functional state of the body and healthy people, without treatment, can be normal study, work and life, just do not forget to check regularly. Young male and female hepatitis B virus carriers should not be restricted in their love and marriage, and female carriers can have healthy children, but they need to go to a specialist hospital for consultation and examination before pregnancy and childbirth.
Support Us
Discussion
Share your experience, or seek help from fellow patients.
